CABA

Cabaletta Bio Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↓ 4/10
  • Value↓ 4/10
Cabaletta Bio sales and earnings growth
CABA Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 24.80%
  • FCF Y/Y↓ -47.38%
Cabaletta Bio gross and profit margin trends
CABA Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -281.32%
Cabaletta Bio net debt vs free cash flow
CABA Risk
Great
  • Debt / Equity↓ 0.3
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -73.8

Cabaletta Bio stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks